All News about Amicus Therapeutics
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2023
September 01, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Amicus Therapeutics: Q1 Earnings Insights
May 10, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for Amicus Therapeutics
March 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_133.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Preview: Amicus Therapeutics
February 28, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU1.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/10/aapharma_7.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/25/jim_cramer_scotte_beale.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/3485317b-58e2-4b0a-8e4c-4b45ad57718a/small/amicus-logo-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.